Advertisement

Topics

Xavant secures FDA nod for non-invasive pain relief neuromodulation device

01:56 EDT 2 Aug 2017 | Medical Business Review

Xavant Technology has secured approval from the US Food and Drug Administration (FDA) for its Stimpod NMS460 non-invasive neuromodulation device to treat chronic intractable pain.

Original Article: Xavant secures FDA nod for non-invasive pain relief neuromodulation device

NEXT ARTICLE

More From BioPortfolio on "Xavant secures FDA nod for non-invasive pain relief neuromodulation device"

Quick Search
Advertisement
 

Relevant Topics

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...

Anesthesiology
An anesthesiologist (US English) or anaesthetist (British English) is a physician trained in anesthesia and perioperative medicine. Anesthesiologists are physicians who provide medical care to patients in a wide variety of (usually acute) situations. ...